Description
MK-3697 is a selective orexin 2 receptor antagonist.
| Product Unit Size | Cost | Quantity | Stock |
|---|
MK-3697 is a selective orexin 2 receptor antagonist.
| Cas No. | 1224846-01-8 |
|---|---|
| Purity | ≥98% |
| Formula | C23H21N5O3S |
| Formula Wt. | 447.5 |
| Chemical Name | N-[(5,6-dimethoxypyridin-2-yl)methyl]-2-(5-methylpyridin-3-yl)-5-(1,3-thiazol-2-yl)pyridine-4-carboxamide |
| IUPAC Name | N-[(5,6-dimethoxypyridin-2-yl)methyl]-2-(5-methylpyridin-3-yl)-5-(1,3-thiazol-2-yl)pyridine-4-carboxamide |
| Synonym | MK3697; M8238285OA; (2,3'-Bipyridine)-4-carboxamide, N-((5,6-dimethoxy-2-pyridinyl)methyl)-5'-methyl-5-(2-thiazolyl)- |
| Solubility | Insoluble in water. DMSO (>20 mg/mL). |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Roecker AJ, Reger TS, Mattern MC. et.al. Discovery of MK-3697: a selective orexin 2 receptor antagonist (2-SORA) for the treatment of insomnia. Bioorg Med Chem Lett. (2014) 24:4884-90. PMID: 25248679 DOI: 10.1016/j.bmcl.2014.08.041.
GABA-A positive modulator.
Polyketide; protein translation inhibitor, mamm...
Derivative of methyl caffeate, hydroxycinnamic ...
PIKfyve inhibitor.
STAT3 inhibitor.
CCK antagonist.
PI3K inhibitor.
Triterpene saponin found in Panax; Kv7.1 K+ cha...
Peptide, involved in neutrophil activation; FPR...
EZH2 HMT inhibitor.
AurKA/B inhibitor.
Endogenous bombesin-related peptide, involved i...
Semi-synthetic vinca alkaloid found in Catharan...
Fermentation impurity
Aminoglycoside; protein translation inhibitor, ...
Dihydropyridine; L-type Ca2+ channel blocker.
Taxane found in species of Taxus; potential mic...
Aspartyl protease inhibitor.
Peptide fragment of VSV; LDLR agonist.
Alkaloid found in Catharanthus, precursor in sy...